Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $295.0M
Liabilities Breakdown FY2014
Total Liabilities: $47.4M
Asset Breakdown
Total Assets: $295.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $73.6M | 24.9% |
| Accounts Receivable | $2.4M | 0.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $38.5M | 13.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $5.9M | 2.0% |
| Other Assets | $174.7M | 59.2% |
Liabilities Breakdown
Total Liabilities: $47.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.4M | 26.2% |
| Long-Term Debt | $1.5M | 3.1% |
| Other Liabilities | $33.5M | 70.7% |